Stem cell therapies seem to be an appropriate tool for the treatment of a variety of diseases, especially when a substantial cell loss leads to a severe clinical impact. This is the case in most neuronal cell losses. Unfortunately, adequate neural stem cell sources are hard to find and current alternatives, such as induced programmed stem cells, still have incalculable risks. Evidence of neurogenesis in the adult human enteric nervous system brought up a new perspective. In humans the appendix harbors enteric neuronal tissue and is an ideal location where the presence of neural stem cells is combined with a minimal invasive accessibility. In this study appendices from adults and children were investigated concerning their neural stem cell potential. From each appendix tissue samples were collected, and processed for immunohistochemistry or enteric neural progenitor cell generation. Free-floating enteric neurospheres (EnNS’s) could be generated after 6 days in vitro. EnNS’s were either used for transplantation into rat brain slices or differentiation experiments. Both transplanted spheres and control cultures developed an intricate network with glia, neurons and interconnecting fibers, as seen in primary enteric cultures before. Neuronal, glial and neural stem cell markers could be identified both in vitro and in vivo by immunostaining. The study underlines the potential of the enteric nervous system as an autologous neural stem cell source. Using the appendix as a potential target opens up a new perspective that might lead to a relatively unproblematic harvest of neural stem cells.
Citation: Hagl CI, Heumüller-Klug S, Wink E, Wessel L, Schäfer K-H (2013) The Human Gastrointestinal Tract, a Potential Autologous Neural Stem Cell Source. PLoS ONE 8(9): e72948. https://doi.org/10.1371/journal.pone.0072948
Editor: Jialin Charles Zheng, University of Nebraska Medical Center, United States of America
Received: January 8, 2013; Accepted: July 15, 2013; Published: September 4, 2013
Copyright: © 2013 Hagl et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: Funding was supported by a university grant (Hochschulfonds). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Stroke, cerebrovascular disease and neurodegeneration are major causes of mortality and disability . Their common characteristics are a progressive loss of structure and function  that cannot be overcome by healing processes. Despite dramatic advancements in medical care, effective clinical therapies are limited and therapeutic strategies that restore neuronal and glial cells as well as functional circuits are lacking. Neurodegeneration predominantly affects specific neuronal populations, like dopaminergic neurons in Parkinson’s disease  or cortical and hippocampal neurons in Alzheimer’s disease . In brain injury the affected area comprises a wide range of neuronal and connective tissues , . Furthermore the regenerative processes have both beneficial and detrimental effects. Surrounding glial cells even contribute to the pathologic processes by forming a glial scar ,  or supporting neurotoxicity in neurodegenerative diseases . Therapeutic strategies therefore should facilitate endogenous regeneration, attenuate neurotoxic effects and achieve functional improvement. Stem cell transplantation therefore has emerged as a potential therapeutic approach for cell replacement in ischemic brain injuries or neurodegenerative diseases –.
Therapeutic studies with embryonic tissue, autologous cell sources and mesenchyme or induced pluripotent stem cells still have their drawbacks –. The potential tumorigenicity of transplants derived from embryonic stem cells, ethical concerns and a limited availability of standardized, viable and pure embryonic stem cells make it unlikely that embryonic stem cell transplantation will become a routine treatment in the near future . Autologous cell sources circumvent ethical problems and the need for immunosuppression but depend on appropriate sources, which yield sufficient amounts of donor cells in appropriate quality. The discovery of neural stem cell niches in the adult brain has raised the possibility of endogenous neuronal replacement for neuronal tissue repair. But in the normal human brain, progenitor cells in the subventricular zone (SVZ) are present in relatively low abundance and the tissue damage might also affect the neurogenic niches. Moreover, to isolate sufficient amounts of donor tissue from the SVZ is a risk in itself and might destroy the niche properties. In particular, many stroke patients have infarcts located close to the SVZ  and a number of studies showed changes in the amount of proliferating cells in the human brain SVZ in Parkinson’s (PD) and Alzheimer’s disease (AD) , .
Mesenchyme and induced pluripotent stem cells (iPSC’s) are a promising source of multipotent self renewing cells but have to be redifferentiated into lines with complex neuronal diversity (e.g. cholinergic or dopaminergic neurons) before transplantation . But the programming and differentiation of iPSC’s is challenging and they also carry the risk of tumorgenesis or cytogenetic abnormalities as a result of extensive in vitro manipulation. To precede stem cell transplantation into a feasible treatment for neuronal tissue loss therapeutic approaches must combine a neural stem cell source that persists into adulthood with an easy and minimal invasive access. Ideally the stem cell niche contains progenitors, which maintain their plasticity and differentiation potential in culture . The transplanted neural precursors may then assimilate and constitute a neural network similar to that lost in disease . Alternatively, stem cells might provide environmental enrichment to facilitate host neurons by producing neurotrophic factors, attenuate toxic influences, or create supplementary neuronal networks around affected tissues –.
For central nervous system (CNS) repair the gastrointestinal tract with its neural crest derived neuronal and glial cells; the enteric nervous system (ENS) harbours a potent and easily accessible autologous source , . Moreover, due its similarities with the central nervous system (CNS) such as its complex neuronal organization, the neurotransmitter spectrum and chemical coding  the ENS is a excellent neural stem cell source for cell replacement therapies. Neural crest derived stem cells are responsible for the plasticity in the ENS, which is to be seen all over its life span . Autologous cell therapy for neurological and intestinal disorders has to be advanced, and enteric stem cells may become the ideal candidate for neural cell transplantation. Neural stem cells isolated from the ENS proliferate and form in vitro neurospheres that maintain both the capability of self renewal and the ability to differentiate into neurons and astrocytes –. The appendix, as an abdicable part of the intestine, might be the appropriate location with a sufficient amount of enteric nervous tissue  where neural stem cells are easily harvested.
We therefore used appendices from patients at different ages to cultivate and differentiate enteric neurospheres from adult human tissue. The cultivated enteric neurospheres (EnNS’s) demonstrated specific stem cell characteristics as confirmed by immunofluorescence staining and qPCR, while neuronal and glial cells could be derived from these EnNS’s. To proof the hypothesis, that these enteric neural cells are a possible source for CNS tissue replacement a pilot study was performed. To proof its feasibility EnNS’s derived from postnatal intestinal tissue were transplanted into rat brain slices and investigated concerning their behavior. In parallel, neurospheres from newborn rats were generated routinely to establish and improve the transplantation procedures. During the observation period the neuronal and glial precursor cells survived, migrated and differentiated while constituting an intricate neuronal network inside the brain slices. In conjunction with various neuronal phenotypes, like catecholaminergic neurons in the EnNS’s this autologous neural stem cell treatment might be a feasible, minimally invasive, safe, and effective approach for neuronal cell replacement even in brain injury and neurodegenerative disease.
Materials and Methods
All tissues (whole intestine and brain slices) were dissected from eight days old (p8) Sprague Dawley (SD) rats.
This study was carried out in strict accordance with the recommendations for the care and use of laboratory animals of the German animal protection law. The experiments were performed after killing the animal by decapitation to minimize suffering, and only based on the post mortem removal of tissue. Following §6 of the German animal law, the tissue removal has only to be indicated. The study was approved by the local ethical committee (Med. Ethik-Kommission II, Medical Faculty Mannheim).
Human Postnatal Appendices
Appendices from children and adults (age ranged from 6 month to 69 years) with either appendicitis or tumor resection were obtained from two surgical centers. A total of 81 tissue samples were included in the study. All samples were collected after written informed consent of the patients or the parents, following the Helsinki declaration and with the approval of the local ethical committee (Med. Ethik-Kommission II, Medical Faculty Mannheim, 2010–352N-MA).
Generation of Rat Enteric Neurospheres (rEnNS’s)
Briefly, rats were decapitated, the whole intestine removed and immediately stored in MEM (Gibco) on ice. The muscle and submucous layer were separated, and the dissected muscle tissue incubated in a collagenase II solution (Worthington) for 2 hours. After vortexing the tissue for 20 seconds the suspension was filtered through a sterile syringe filter (Cell strainer, BD biosciences), pore size 40 µm. The supernatant was centrifuged three times, the obtained myenteric plexus incubated in accutase (PAA Laboratories GmbH) for 20 minutes and dissociated by trituration. In a second centrifugation step, the accutase was removed and replaced with 10 ml culture medium. The cells were kept at standardized densities (1×106 cells/25 cm2 flask) in culture medium adapted for expansion cultures [Neurobasal A (Gibco) supplemented with 2% B27- (without vitamin A, Gibco), 1% albumin (Sigma), 0.25% -2-mercaptoethanol (50 mM, Invitrogen), 0.12% glutamine (200 mM, Sigma), EGF (10 ng/ml, Tebue), bFGF (20 ng/ ml; Tebue), GDNF (10 ng/ml, Tebue), gentamycin and metronidazole (100 µg/ ml)]. After two days in vitro, the first floating neurospheres (EnNS’s) were seen, while neurons and radiating glial cells expanded at the bottom.
Generation of Human Enteric Neurospheres (huEnNS’s)
The tissues were stored in MEM-Hepes (Gibco) on ice immediately after surgery. Tissue samples for immunohistochemistry were removed and the remaining tissue processed for the isolation of human ENS’s. To generate huEnNS’s we modified the method published for embryonic gut tissue . After separation of the submucous and muscular layer the tissue was enzymatically digested with collagenase II solution (Worthington) for 4 hours as described above for the rat intestine. Pure myenteric (MP) and submucous plexus (SMP) were isolated until all available enteric tissue could be obtained. The collected ganglia were mildly dissociated with accutase (PAA Laboratories GmbH) for 20 min and plated in 25 cm2 culture flasks (Nunc) at standardized densities (1×106 cells/flask) using a standard neuronal medium [Neurobasal A (Gibco) supplemented with 2% B27- (without vitamin A, Gibco), 1% albumin (Sigma), 0.25% 2-mercaptoethanol (50 mM, Invitrogen), 0.12% glutamine (200 mM, Sigma), bFGF (20 ng/ml, Tebue), GDNF (10 ng/ml, Tebue), EGF (10 ng/ml, Tebue), gentamycin and metronidazole (100 µg/ml)]. After 6 days in vitro free-floating enteric neurospheres (EnNS’s) were abound, while differentiating neurons and glia cells at the bottom could easily be discriminated. The supernatant with EnNS’s and differentiation neuronal and glial cells was cultivated further. The EnNS’s cultures were maintained up to 40 days at 37°C in a humified atmosphere (5% CO2). Every three days, half of the volume was replaced with fresh medium.
Rat and Human Enteric Neurospheres (EnNS’s) Differentiation
After five days in vitro, the floating EnNS’s were harvested and utilized either for differentiation experiments or for transplantation. Rat EnNS’s or dissociated single cells were suspended in extra cellular matrix (ECM) gel (Sigma) and plated on coverslips in 24 well plates (Becton Dickinson). The ECM gel plugs were allowed to gel at 37°C for several minutes and topped with cultured medium for differentiation [Neurobasal A (Gibco) supplemented with 2% B27+ (with vitamin A, Gibco), 1% albumin (Sigma), 0.25% 2-mercaptoethanol (50 mM, Invitrogen), 0.12% glutamine (200 mM, Sigma), bFGF (20 ng/ml; Tebue), GDNF (10 ng/ml, Tebue), Neurturin (10 ng/ml Tebue), gentamycin and metronidazole (100 µg/ml)]. After 48h in vitro the EnNS’s and single cell cultures were fixed with 4% formaldehyde for 10 min and stored in phosphate buffered saline (PBS).
Generation of Rat Brain Slice Cultures
Eight days old SD rats were used for slice culture preparation. After decapitation the brains were dissected under sterile conditions . The frontal pole and the cerebellum were removed and the brains were placed in preparation medium, containing minimum essential medium (MEM, Gibco) with 1% glutamax (Gibco), 0.45% glucose (Sigma), 2.5% HEPES 1M, 0.1 mg/mL streptomycin (Sigma), 100 U/ml penicillin (Sigma) at pH 7.35 and 4°C. Approximately one mm of the brain from rostral to caudal were removed and 400 µm thick slices were prepared with a vibratome (Leica). Four to six brain slices were obtained and used for further experiments. The slices were immediately transferred into cell culture inserts (Becton Dickinson, pore size 0.4 mm) into six well plates (Becton Dickinson) containing 1 ml culture medium per well . Culture medium consists of 42 ml MEM (Gibco), 25 ml basal medium eagle (BME, Gibco), 25 ml normal horse serum (NHS; Gibco), 1 ml glutamax (Invitrogen), 1.5 ml glucose (45%, Sigma), 2.5 ml HEPES 1M (Sigma), 2 ml bicarbonate (7.5%, Invitrogen), 0.1 mg/ml streptomycin (Sigma), 100 U/ml penicillin (Sigma) at pH 7.30. The brain slices were incubated at 37°C in humified atmosphere with 5% CO2. Brain slices were hosted up to 5 days before transplantation.
The EnNS’s were stained with a vital cell tracer (CFSE, Invitrogen) following the manufacturer’s protocol. Extracellular matrix proteins provide an important framework for the enteric microenvironment during the process of enteric neuronal differentiation . To preserve normal cellular interactions in culture the stained EnNS’s were suspended in ECM (Sigma) for differentiation and cell transplantation experiments. ECM gel (2 µl) containing approximately 250 EnNS’s was transplanted into cerebral cortex lesions (200 µm diameter), which were punched into the slices. The brain slices with ECM gel-EnNS’s transplants were kept in vitro up to 4 days at 37°C, 5% CO2. Slices were fixed with 4% formaldehyde solution in phosphate buffered saline (PBS) for 24 hours.
Immunohistochemistry and Immunocytochemistry
Human and rat EnNS’s.
Differentiated EnNS’s or single cell cultures from human appendices (huEnNS’s) and rat intestine (rEnNS’s) were stained for Nestin, Sox2, ß-Tubulin III, Oct4, Nanog and TH.
The cultures were washed with PBS, followed by 45 min 0.5% triton X-100 and blocked in 10% normal goat serum for one hour. Primary antibodies for Nestin (Millipore, mouse-anti-Nestin [1∶200]), Nanog (R&D System, goat-anti-Nanog [1∶20], Sox2 (R&D System, maus-anti-Sox2 [1∶50]), Oct4 (Abcam, rabbit-anti-Oct4 [1∶200], ß-Tubulin III (Millipore, mouse-anti-Tubulin [1∶1000]) and TH (Chemicon, sheep-anti-TH [1∶500] were added and incubated over night at 4°C. The specimen were washed three times with PBS and incubated with secondary antibodies (Alexa® 488 anti-mouse-IgG, Alexa® 488 anti-rabbit-IgG, Alexa® 488 anti-goat-IgG or Cy3 anti-sheep-IgG Chemicon) for four hours at room temperature (RT). 4′, 6-diamidino-2-phenylindole (DAPI) (Sigma, 0.3 µg/ml) was used as nuclear stain.
After staining of rEnNS’s and single cells from rat dissociated rEnNS’s the protein expression for Nestin, Nanog, Sox2, Oct4, ß-Tubulin III and TH were quantified against the DAPI stained rEnNS’s and single cells from dissociated rEnNS’s (n = 3).
Human appendices were fixed in 4% formaldehyde in PBS and embedded in paraffin. Adjacent sections of 10 µm were cut on a microtome (Leica). After dewaxing and rehydrating, the sections were washed in 0.05% tween and after antigen retrieval in citrate buffer (30 min, 95°C, pH 6.0) tissue were allowed to cool for 30 min at RT. After blocking with normal goat serum the tissues were incubated in an antiserum raised against the neuronal marker PGP 9.5 (Dako, [1∶500]) or sheep-anti-TH (Chemicon, [1∶500]) over night at 4°C. The detection of PGP 9.5 antigen was carried out with the EnVision+ System-HRP for use with rabbit secondary antibodies (Dako). DAB was used as a chromogen to localize the peroxidase in our tissue sections whereas the detection of TH was carried out with Vectastain Elite ABC kit (Linaris) according to the manufacture’s protocol. After the DAB reaction, the sections were dehydrated and mounted in Neo-Mount (Merck).
Brain slices with transplanted EnNS’s.
The rat brain slices were stained for TH and ß-Tubulin III, GFAP and Nestin. The slices were washed with PBS, followed by 45 min 0.5% triton X-100 and blocked in 10% normal goat serum for one hour. Primary antibodies for Nestin (Millipore, mouse-anti-Nestin [1∶200]), ß-Tubulin III (Millipore, mouse-anti-Tubulin [1∶1000]), GFAP (Dako, rabbit-anti-GFAP [1∶500]) and TH (Chemicon, sheep-anti-TH [1∶500] were added and incubated over night at 4°C. The slices were washed three times with PBS and incubated with secondary antibodies (Alexa® 546 anti-mouse-IgG, Alexa® 546 anti-rabbit-IgG or Cy3 anti-sheep-IgG, Chemicon) for four hours at RT. DAPI (Sigma, 0.3 µg/ml) was used as nuclear stain.
Real-time PCR analysis of gene expression.
Total cellular RNA from EnNS’s and neuronal cells was extracted using an Isolate RNA Mini Kit (Bioline, Luckenwalde, Germany) following the manufacturer’s protocol. Contaminating genomic DNA was digested with DNAse I (Invitrogen, Karlsruhe, Germany). RNA concentration was determined spectrophotometrically with the infinite M200 micro plate reader (Tecan, Mainz-Kastel, Germany) and RNA quality assessment was tested with RNA 6000 Nano Kit (Agilent Technologies, Waldbronn, Germany) and the Agilent Bioanalyzer 2100 (Agilent Technologies, Waldbronn, Germany).
BioScript TM was used to generate cDNAs (Bioline, Luckenwalde, Germany). For real time PCR the SensiMixSYBR Low-Rox Kit (Bioline, Luckenwalde, Germany) was used on a MX3005 (Stratagene, Amsterdam, Netherlands). Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as an internal standard. The PCR conditions were as follows: initial denaturation 10 min, 95°C, 40 cycles of denaturation, 30 sec., 95°C; annealing, 30 sec., 56°C (nestin, GAPDH); 30 sec., 72°C. The Primer sequences (F: forward; R: reverse) were as follows: human Nestin (F: 5′-CTCCAAGAATGGAGGCTGTAGGAA-3′, R: 5′-CCTATGAGATGGAGCAGGCAAGA-3′) and human GAPDH (F: 5′-GCACCGTCAAGGCTGAGAAC-3′, R: 5′-TGGTGAAGACGCCAGTGGA-3′), from . For rat Nanog (F: 5′-TTGGAACGCTGCTCCGCTCC-3′, R: CGCCTGGCTTTCCCTAGTGGC-3′), rat Sox2 (F: 5′-ACTAATCACAACAATCGCGGCGGC-3, R: 5′-GACGGGCGAAGTGCAATTGGGA-3′) rat Oct4 (F: 5′-GGAGGGATGGCATACTGTGGACCT-3′, R: 5′-TCCTGGGACTCCTCGGGACTAGG-3′) from  and rat GAPDH (F: 5′-GTATGACTCTACCCACGGCAAGT-3′, R 5′-TTCCCGTTGATGACCAGCTT-3′) from  were used. Data were normalized for GAPDH mRNA expression using the delta-delta-CT method. Data is expressed as the mean ± SEM and tested for statistical significance using student’s t-test. The results were considered significant if the probability of error (P) was *P<0.05.
Potent ENS Precursor Cells are Derived from Enteric Plexus
The free floating EnNS’s from rat culture preparations were dissociated and cultivated. Within 48 hours the dissociated neural spheres and isolated neural cells developed an intricate network with glia, neurons and interconnecting fibers, as seen in primary enteric cultures before. Immunostaining with Nestin, Nanog, Sox2, Oct4, ß-Tubulin III, and TH were positive in different cell types (Fig. 1 A–L). The expression of Nanog, Sox2 and Oct4 in rEnNS’s was confirmed in the real-time PCR experiments (Table S1).
Rat EnNS’s (A, C, E, G, I) and single cells from dissociated rEnNS’s (B, D, F, H, J, L) were fixed and stained after 48 hours in vitro with various stem cell (A–H) and neuronal markers (I–L). The cells were immunostained with the markers for Nestin (A, B), Nanog (C, D), Sox2 (E, F) Oct4 (G, H), ß-Tubulin III (I, J) and TH (K, L). DAPI was used as a nuclear stain.
The neural spheres and isolated cells revealed stem cell characteristics as well as qualities of neuronal and glial cells. The neural spheres had a positive immunostaining for the neuroepithelial stem cell marker Nestin (Fig. 1 A, B) and ß-Tubulin III (Fig. 1 I, J). Nestin positive cells can be regarded as neural progenitor cells , , while ß-Tubulin III positive cells are possibly differentiating neuronal cells . Furthermore the generated EnNS’s were also positive for Nanog (Fig. 1C, D), Sox2 (Fig. 1 E, F) and Oct4 (Fig. 1 G, H). Sox2 as well as Oct4 is a transcription factor essential for maintaining self-renewal or pluripotency of undifferentiated embryonic stem cells . Together with Oct4 it forms a heterodimer and binds DNA , . Nanog is a protein expressed in embryonic stem cells and is together with Sox2 and Oct4 thought to be a key factor in maintaining pluripotency , . The presence of TH positive cells (Fig. 1 K, L) demonstrates that these EnNS’s derived from the gastrointestinal tract might give rise to a dopaminergic neuronal cell fate. The statistical evaluation revealed an abundant protein expression, while in the dissociated cell preparation the protein expression decreased significantly (Fig. 2). The rEnNS’s demonstrated an abundant expression of Nestin, Nanog, Sox2 and Oct4 while in the dissociated single cells only 6% of the cells expressed pluripotence genes (Sox2, Oct4) and 26.3% (Nestin) respectively 19% (Nanog) demonstrated stem cell characteristics. In contrast the TH expression was to be seen in 16.7% of the dissociated neural cells.
Rat Derived EnNS’s (rEnNS’s) Transplantation
EnNS’s from the rat intestine were transplanted into rat brain slices. After injury the transplanted CFSE marked rEnNS’s could be clearly seen within the brain slice. Microscopic tracking of the transplants in brain slice culture was possible for up to five days; beyond this the clear detectable CFSE signal vanished due to cell growth and migration into the brain slice (3 A–C). In vitro transplanted rEnNS’s survived for more than four days, differentiated and migrated into rat brain slices (Fig. 3A). Microscopic observation of the transplants revealed neurite outgrowth and network formation, while the transplanted cells also formed interconnections with the surrounding tissue.
rEnNS’s were stained with CFSE and transplanted into the cortical layer of a rat brain slice. (A, B and C). Within for days the surviving transplanted cells migrated into the cortical layers. At two distant regions (white squares) the transplanted cells are shown in a magnification. Rat brain slice with CFSE labelled rEnNS’s (green) transplants were immunostained with TH (red) (B) and ß-Tubulin III (red) (C). For single cells a co-labelling for CFSE-stained transplants and TH (B, arrowheads) as well as for CFSE-stained transplants and ß-Tubulin III was seen (C, arrowheads). DAPI was used as a nuclear stain.
Immunohistochemical staining with TH and ß-Tubulin III revealed a strong signal for all staining. For ß-Tubulin III and TH a co-labeling in transplanted neural cells could be demonstrated (Fig. 3C, D). This finding proves the in situ differentiation of the transplanted cells.
Appendices from 81 patients (59 children, aged 1 to 12 years; 29 girls, 30 boys and 22 adults, aged 16 to 67 years; 13 female, 9 male patients) were obtained and prepared for huEnNS’s culture and immunostaining. All children and 17 adult patients had appendectomy due to inflammation; the other patients underwent a colectomy because of adenocarcinoma. All together 55 appendices could be processed within 24 hours, while 26 specimens were stored in MEM over 24 hours and were used for immunostaining only.
Immunostaining of Human Tissue
A whole appendix (A) is stained with the pan neuronal marker PGP9.5 and in the enteric plexus (B). TH positive cells could be demonstrated in the submucous (C, arrowheads) and myenteric (D, arrowheads) plexus.
TH as the rate-limiting enzyme for catecholamine biosynthesis is present in all central and peripheral neurons, which utilize the neurotransmitters dopamine, epinephrine and norepinephrine . Therefore the appendices were also stained for TH . In all stained tissues the markers demonstrated a clear signal within the submucous and myenteric plexus (Fig. 4 A–D). Especially TH positive neurons could be found (Fig. 4C, D), suggesting that these neurons are progeny from neural crest derived cells that differentiate into catecholaminergic neurons.
Human Enteric Neurospheres (huEnNS’s) are Derived from Human Appendix
According to the previously described method ,  it was possible to isolate submucous (SMP) and myenteric plexus (MP) from most of the human appendices (Fig. 5A, B). After incubating the samples in a collagenase solution usually only single cells could be isolated (Fig. 5C). In culture first adherent neurons and glia could be detected. While the differentiated neuronal and glial cells disappeared in vitro, another round shaped cell type started to proliferate within 5–7 days, forming growing cell clusters. These huEnNS’s were free floating cell clusters without processes (Fig. 5D, E). In the culture preparation with appendices from children younger than 5 years first huEnNS’s could be seen after three days while cultures from patients older than 65 years first huEnNS’s appeared after ten days. Myenteric plexus preparation yielded 378±50 huEnNS’s per preparation, while the submucous plexus yield was 518±50 huEnNS’s. In general the submucous plexus preparation showed an increased growth potential but was more often prone to bacterial overgrowth, especially after storage or transportation times of more than 12 hours.
The human appendix as used (A). The appendix was separated in the mucosa and muscular layer (arrowheads) under visual control (B). After the preparation procedure single cells could be isolated (C). Depending on the donors age within 5 to 15 days EnNS’s could be detect. Sphere from the submucous (D) and the myenteric plexus (E).
Secondary and tertiary human enteric nervous system neurospheres can be exponentially expanded by repeated dissociation without deficiency in their differentiating potential . The same characteristics persisted in our cultures up to 40 days or until we used them in other experiments. Taken as a whole 62% (34 appendices) of the culture preparations lead to successful huEnNS’s generation, while bacterial overgrowth impeded it in 27% (15 appendices) and for 11% (6 appendices) of the harvested plexus preparation no reason for the failure was obvious.
Potent ENS Precursor Cells are Derived from Human Enteric Plexus
The free floating huEnNS’s from both, MP and SMP culture preparations were harvested, dissociated and cultivated for differentiation (Fig. 6 and 7). Planted huEnNS’s showed neurite outgrowth within 12 hours, which led to network formation. In cultures of dissociated huEnNS’s cells, neuronal cells with interconnecting nerve fibers and glia cell morphology could be discriminated within 48 hours.
huEnNS’s (A, C, E, G, I) and single cells from dissociated huEnNS’s (B, D, F, H, J and L). huEnNS’s and single cells were stained with the same stem cell and neuronal markers as used in the rat. Nestin (A, B), Nanog (C, D), Sox2 (E, F) and Oct4 (G, H) as stem cell markers, ß-Tubulin III (I, J) and TH (K, L) for neuronal cells. DAPI was used as a nuclear stain.
huEnNS’s (A, C, E, G, I) and single cells from dissociated huEnNS’s (B, D, F, H, J and L). huEnNS’s and single cells were stained with the same stem cell and neuronal markers as used in the rat. Nestin (A, B), Nanog (C, D), Sox2 (E, F) and Oct4 (G, H) served as stem cell markers, ß-Tubulin III (I, J) and TH (K, L) for neuronal cells. DAPI was used as a nuclear stain.
The neural spheres and isolated cells from MP and SMP also revealed stem cell characteristics as demonstrated by the immunoreactivity for Nestin (Fig. 6A, B: SMP; Fig. 7 A, B: MP), Nanog (Fig. 6C, D: SMP, Fig. 7C, D: MP), Sox2 (Fig. 6E, F: SMP, Fig. 7E, F: MP) and Oct4 (Fig. 6G, H: SMP, Fig. 7 G, H: MP). Furthermore the generated huEnNS’s were also positive for ß-Tubulin III (Fig. 6I, J: SMP, Fig. 7 I, J: MP) and TH (Fig. 6 K, L: SMP, Fig. 7 K, L: MP) confirming their neuronal characteristic and the potential to give rise to a dopaminergic neuronal cell fate. Induced pluripotent stem cells (iPSC’s) were used as positive control for Nanog and Oct4 (Figure S1). Real-time PCR analysis also revealed a significant increase of Nestin in SMP (7.86±4.23) and MP (4.62±1.67) spheres compared to differentiated neurons that served as control (Table S1).
Human EnNS’s Transplantation
As a proof of principal huEnNS’s were transplanted into rat brain slices. After injury the transplanted CFSE marked huEnNS’s could be clearly seen within the brain slice. During cultivation over at least four days transplanted huEnNS’s derived from SMP and MP survived, differentiated and migrated into rat brain slices (Fig. 8). Microscopic observation in culture revealed neurite outgrowth and network formation. The transplanted cells also formed interconnections with the surrounding tissue.
huEnNS’s from the human appendix were stained with CFSE (green) and then transplanted in the cortical layer of a rat brain slice. (A) Complete rat brain slice after 4 days of transplanted human EnNS’s. The area of the transplant is seen in the cortical layer, while EnNS’s, which migrated over four days into the brain slice are seen in the inner layers (B, C) Parts of growing transplanted and differentiated spheres in the rat brain slice. Cells that migrate from the transplant (white square, A) are shown in magnification (B, C). With the CFSE fluorescence single cells can be discriminated and the intricate network formation is explicit mapped (C). Rat brain slice transplanted with CFSE labelled neuronal spheres (green) from the human appendix were immunostained with (D, E) GFAP and DAPI, (F) ß-Tubulin III and DAPI and (G) Nestin and DAPI. A co-labelling for CFSE labelled and ß-tubulin III positive cells (F, yellow cells, arrowheads) as well as for CFSE labelled and nestin positive cells (G, yellow-green cells, arrowheads) could be shown.
After four days in vitro the brain slices containing human derived EnNS transplants were fixated and stained against glial fibrillary acidic protein (GFAP), ß-Tubulin III and Nestin (Fig. 8 A–G). In the surrounding neuronal tissue indigene GFAP positive glial cells recreated interconnections, as described for reactive gliosis . But at the transplant/host border there were also transplanted EnNS’s to be seen that passed across the astroglial border. For ß-Tubulin III (Fig. 8F) and Nestin (Fig. 8G) a co-labeling for transplanted and indigene neuronal cells could be demonstrated, similar to the rat cultures.
In this presented work we demonstrated the ability to cultivate and differentiate enteric neurospheres (EnNS’s) from human appendix tissue of all ages. The appendix as an easy accessible part of the intestine can be used for neural stem cell generation. With minimal invasive surgical techniques the appendectomy is not harmful, even in diseased patients . In ischemic stroke multiple cell types like neurons, glial cells and blood vessels are lost while in neurodegeneration predominantly neuronal subpopulations are affected. Ideally, the cell replacement therapy involves comprehensive replacement or induction of various cell types. The enteric nervous system with its intimate contact to luminal contents of the gut is in contrast to the CNS permanent challenged. Due to dietary habits, mechanical bowel movements and inflammatory responses, the ENS has to handle tissue damage or neuronal cell loss continuously , . Replacement of lost neuronal and glia cells might be one of the concepts for the lifelong intestinal plasticity , , . The ENS does not only host an active stem cell niche with neuronal and glial precursors it is also able to support vascular regeneration . In the human CNS blood vessels originate from extrinsic cell populations, which interact with glia and neurons to establish the blood brain barrier and control cerebrovascular exchanges. Furthermore neurovascular interactions play an important role in adult neurogenic niches as indicated by intimately associated neural stem cells with blood vessels . In an actual study we could demonstrate that co-cultivation of EnNS’s with mesenteric vascular cells (MVC’s) facilitates neuronal regeneration and tube formation . The generated neurospheres and/or dissociated cells showed characteristics of neural stem cells (Nestin, Nanog, Sox2 and Oct4 positive), differentiating and mature neurons (ß-Tubulin III positive, Tyrosine Hydroxylase (TH) positive). These tremendous Nestin expression has been described in enteric stem cells from rat embryonic gut , substantiating the presumption that the derived EnNS’s are pluripotent and can be differentiated into neuronal and glial cells. In contrast, only 6% of the dissociated cells expressed pluripotency genes, which gives evidence for a smaller cell population in the enteric nervous system that remains pluripotent. Such cells have been described in the adult mouse . Hence the enteric nervous system harbors diverse kinds of neuronal stem cells that give rise to subtypes of neuronal and glial cells. In particular the verification of TH positive neurons in the appendix, together with the expression of several key molecules for pluripotency, make these cells enormously valuable for regenerative cell therapy in neurological disorders such as Parkinson’s disease . Due to the fact, that several of the pluripotency genes are already expressed, these cells might easily be transformed into induced pluripotent stem cells (iPSC’s) with a little amount of reprogramming. Furthermore as the enteric neurons are neural crest derived  it is very likely that TH positive neurons in central and enteric nervous system are progeny from the same source, suggesting that enteric neurons might smoothly integrate and reconstitute neuronal function in the CNS. Enteric precursors with a chemical coding and transmitter spectrum similar to the ENS are able to support host neurogenesis. Moreover, the various enteric neuronal populations also comprise cholinergic, serotonergic and catecholaminergic phenotypes .
In our in vitro experiments host astrocytes promoted regeneration as seen by the accumulation of GFAP positive cells along the transplant/host border without entering the transplant. GFAP is expressed in reactive astrocytes that rebuilt the blood brain barrier , , . As the GFAP reactive host cells did not enter the transplanted enteric neurons, the formation of a glial scar has to be assumed in our transplantation experiments. On the other hand a great proportion of transplanted huEnNS’s migrate across the astroglial lining, which indicates a promoted regeneration and neuronal regeneration is also described to occur beyond the glial scar .
Beside the astrocyte response our transplants demonstrated further enormous potential for neurogenesis. Plasticity in the adult CNS depends the constitutive production of neuronal cells and a small proportion of neuronal stem cells have been located in neurogenic areas such as the subventricular zone –. While in neurodegenerative disorders like Parkinson’s disease alterations in the subventricular zone are seen , . ENS precursor cells might be used to create a supportive environment in these weakened neurogenic areas. In Parkinson’s disease (PD) the progressive loss of dopaminergic neurons in the CNS and the presence of cytoplasmic eosinophilic inclusions, the Lewy bodies, are pathological hallmarks , . The ENS of patients with PD also presents Lewy bodies within its enteric plexus  with decreased dopamine neurons  but TH immunoreactive neurons were not altered , . A new studies even states that the ENS is not at all, or much less involved in alterations as presumed .
Studying the ENS for cell replacement therapies might add deeper insights in barriers that have to overcome. In cerebral ischemic stroke an ischemic cascade follows the reduced blood supply thus affecting potentially salvageable tissue . The microenvironment in the gut has continuously to cope with changing cellular interactions, impaired blood supply and inflammation . For instance, the gastrointestinal tract also has a blood ENS barrier and enteric glial cells are key regulators of intestinal barrier functions , . In a rat model transplantation of enteric glia into the spinal chord accelerated blood brain barrier formation .
While mature ENS cells from rodents have been used for central nervous tissue repair , this is the first study which demonstrates the potential of ENS derived neural stem cells from both rodent and human gut and might lay the foundation of future neural stem cell strategies based on the use of ENS derived neural stem cells. Self renewal and differentiation, the attributes of an ongoing neurogenesis proceed in the adult ENS , making it an excellent autologous neural stem cell source. Furthermore the enteric neurospheres are already primed to a neuronal cell fate and should be redifferentiated to iPSC’s with less extensive manipulation. In vivo studies with iPSC’s derived from enteric neuronal tissue will be performed in the near future. All together the ENS seems to be the perfect source not only for catecholaminergic or cholinergic neurons, but also for different glial cell types as just demonstrated  to be used for blood-brain barrier repair or Multiple Sklerosis.
Oct4 and Nanog staining. Induced pluripotent stem cells (iPSC’s) were used as positive control. IPSC’s were stained with either with Oct4 (Abcam, rabbit-anti-Oct4) or Nanog (R&D System, goat-anti-Nanog). DAPI was used as a nuclear stain. In all preparations the signal is explicitly mapped.
We thank Mrs. Karin Kaiser for the excellent technical support. We thank Mrs. Anne Schuster and Mr. Markus Klotz for proof reading the manuscript.
Conceived and designed the experiments: CIH SHK KHS. Performed the experiments: CIH SHK EW KHS. Analyzed the data: CIH SHK KHS. Contributed reagents/materials/analysis tools: LW. Wrote the paper: CIH KHS.
- 1. Mathers CD, Loncar D (2006) Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 3: e442.
- 2. Smith ML, Auer RN, Siesjo BK (1984) The density and distribution of ischemic brain injury in the rat following 2–10 min of forebrain ischemia. Acta Neuropathol 64: 319–332.
- 3. Fearnley JM, Lees AJ (1991) Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 114 (Pt 5): 2283–2301.
- 4. Coyle JT, Price DL, DeLong MR (1983) Alzheimer's disease: a disorder of cortical cholinergic innervation. Science 219: 1184–1190.
- 5. Prabhakaran S, Naidech AM (2012) Ischemic brain injury after intracerebral hemorrhage: a critical review. Stroke 43: 2258–2263.
- 6. Rudge JS, Silver J (1990) Inhibition of neurite outgrowth on astroglial scars in vitro. J Neurosci 10: 3594–3603.
- 7. Sofroniew MV, Vinters HV (2010) Astrocytes: biology and pathology. Acta Neuropathol 119: 7–35.
- 8. Lobsiger CS, Cleveland DW (2007) Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease. Nat Neurosci 10: 1355–1360.
- 9. Marlatt MW, Lucassen PJ (2010) Neurogenesis and Alzheimer’s disease: Biology and pathophysiology in mice and men. Curr Alzheimer Res 7: 113–125.
- 10. Dyson SC, Barker RA (2011) Cell-based therapies for Parkinson’s disease. Expert Rev Neurother 11: 831–844.
- 11. Bellenchi GC, Volpicelli F, Piscopo V, Perrone-Capano C, Porzio UD (2012) Adult neural stem cells: an endogenous tool to repair brain injury? J Neurochem.
- 12. Vescovi AL, Parati EA, Gritti A, Poulin P, Ferrario M, et al. (1999) Isolation and cloning of multipotential stem cells from the embryonic human CNS and establishment of transplantable human neural stem cell lines by epigenetic stimulation. Exp Neurol 156: 71–83.
- 13. Rooney GE, Nistor GI, Barry FB, Keirstead HS (2010) In vitro differentiation potential of human embryonic versus adult stem cells. Regen Med 5: 365–379.
- 14. Yoo J, Kim H, Hwang DY (2012) Stem cells as promising therapeutic options for neurological disorders. J Cell Biochem.
- 15. Hess PG (2009) Risk of tumorigenesis in first-in-human trials of embryonic stem cell neural derivatives: Ethics in the face of long-term uncertainty. Account Res 16: 175–198.
- 16. Delavaran H, Sjunnesson H, Arvidsson A, Lindvall O, Norrving B, et al.. (2012) Proximity of brain infarcts to regions of endogenous neurogenesis and involvement of striatum in ischaemic stroke. Eur J Neurol.
- 17. Winner B, Kohl Z, Gage FH (2011) Neurodegenerative disease and adult neurogenesis. Eur J Neurosci 33: 1139–1151.
- 18. Satija NK, Singh VK, Verma YK, Gupta P, Sharma S, et al. (2009) Mesenchymal stem cell-based therapy: a new paradigm in regenerative medicine. J Cell Mol Med 13: 4385–4402.
- 19. Yan J, Xu L, Welsh AM, Hatfield G, Hazel T, et al. (2007) Extensive neuronal differentiation of human neural stem cell grafts in adult rat spinal cord. PLoS Med 4: e39.
- 20. Lindvall O, Kokaia Z (2006) Stem cells for the treatment of neurological disorders. Nature 441: 1094–1096.
- 21. Rangasamy SB, Soderstrom K, Bakay RA, Kordower JH (2010) Neurotrophic factor therapy for Parkinson’s disease. Prog Brain Res 184: 237–264.
- 22. Pascual A, Hidalgo-Figueroa M, Gomez-Diaz R, Lopez-Barneo J (2011) GDNF and protection of adult central catecholaminergic neurons. J Mol Endocrinol 46: R83–92.
- 23. Chen HC, Ma HI, Sytwu HK, Wang HW, Chen CC, et al. (2010) Neural stem cells secrete factors that promote auditory cell proliferation via a leukemia inhibitory factor signaling pathway. J Neurosci Res 88: 3308–3318.
- 24. Robinson AP, Foraker JE, Ylostalo J, Prockop DJ (2011) Human stem/progenitor cells from bone marrow enhance glial differentiation of rat neural stem cells: a role for transforming growth factor beta and Notch signaling. Stem Cells Dev 20: 289–300.
- 25. Young HM, Newgreen D (2001) Enteric neural crest-derived cells: origin, identification, migration, and differentiation. Anat Rec 262: 1–15.
- 26. Furness J (2006) The Enteric Nervous System. Oxford: Blackwell.
- 27. Gershon M (1998) The second brain. New York: Haper Collins.
- 28. Schafer KH, Van Ginneken C, Copray S (2009) Plasticity and neural stem cells in the enteric nervous system. Anat Rec (Hoboken) 292: 1940–1952.
- 29. Metzger M, Caldwell C, Barlow AJ, Burns AJ, Thapar N (2009) Enteric nervous system stem cells derived from human gut mucosa for the treatment of aganglionic gut disorders. Gastroenterology 136: 2214–2225 e2211–2213.
- 30. Azan G, Low WC, Wendelschafer-Crabb G, Ikramuddin S, Kennedy WR (2011) Evidence for neural progenitor cells in the human adult enteric nervous system. Cell Tissue Res 344: 217–225.
- 31. Hanani M (2004) Multiple myenteric networks in the human appendix. Auton Neurosci 110: 49–54.
- 32. Rauch U, Hansgen A, Hagl C, Holland-Cunz S, Schafer KH (2006) Isolation and cultivation of neuronal precursor cells from the developing human enteric nervous system as a tool for cell therapy in dysganglionosis. Int J Colorectal Dis 21: 554–559.
- 33. Gahwiler BH, Capogna M, Debanne D, McKinney RA, Thompson SM (1997) Organotypic slice cultures: a technique has come of age. Trends Neurosci 20: 471–477.
- 34. Kohl A, Dehghani F, Korf HW, Hailer NP (2003) The bisphosphonate clodronate depletes microglial cells in excitotoxically injured organotypic hippocampal slice cultures. Exp Neurol 181: 1–11.
- 35. Schafer KH, Mestres P (2000) Reaggregation of rat dissociated myenteric plexus in extracellular matrix gels. Dig Dis Sci 45: 1631–1638.
- 36. Wang L, Wang ZH, Shen CY, You ML, Xiao JF, et al. (2010) Differentiation of human bone marrow mesenchymal stem cells grown in terpolyesters of 3-hydroxyalkanoates scaffolds into nerve cells. Biomaterials 31: 1691–1698.
- 37. Yenamandra SP, Darekar SD, Kashuba V, Matskova L, Klein G, et al. (2012) Stem cell gene expression in MRPS18–2-immortalized rat embryonic fibroblasts. Cell Death Dis 3: e357.
- 38. Du F, Wang L, Qian W, Liu S (2009) Loss of enteric neurons accompanied by decreased expression of GDNF and PI3K/Akt pathway in diabetic rats. Neurogastroenterol Motil 21: 1229–e1114.
- 39. Suarez-Rodriguez R, Belkind-Gerson J (2004) Cultured nestin-positive cells from postnatal mouse small bowel differentiate ex vivo into neurons, glia, and smooth muscle. Stem Cells 22: 1373–1385.
- 40. Rauch U, Klotz M, Maas-Omlor S, Wink E, Hansgen A, et al. (2006) Expression of intermediate filament proteins and neuronal markers in the human fetal gut. J Histochem Cytochem 54: 39–46.
- 41. Korzhevskii DE, Karpenko MN, Kirik OV (2011) [Microtubule-associated proteins as markers of nerve cell differentiation and functional status]. Morfologiia 139: 13–21.
- 42. Wegner M, Stolt CC (2005) From stem cells to neurons and glia: a Soxist’s view of neural development. Trends Neurosci 28: 583–588.
- 43. Pan GJ, Chang ZY, Scholer HR, Pei D (2002) Stem cell pluripotency and transcription factor Oct4. Cell Res 12: 321–329.
- 44. Chambers I (2004) The molecular basis of pluripotency in mouse embryonic stem cells. Cloning Stem Cells 6: 386–391.
- 45. Cavaleri F, Scholer HR (2003) Nanog: a new recruit to the embryonic stem cell orchestra. Cell 113: 551–552.
- 46. Yates A, Chambers I (2005) The homeodomain protein Nanog and pluripotency in mouse embryonic stem cells. Biochem Soc Trans 33: 1518–1521.
- 47. Sidebotham EL, Woodward MN, Kenny SE, Lloyd DA, Vaillant CR, et al. (2001) Assessment of protein gene product 9.5 as a marker of neural crest-derived precursor cells in the developing enteric nervous system. Pediatr Surg Int 17: 304–307.
- 48. Molinoff PB, Axelrod J (1971) Biochemistry of catecholamines. Annu Rev Biochem 40: 465–500.
- 49. Young HM, Ciampoli D, Hsuan J, Canty AJ (1999) Expression of Ret-, p75(NTR)-, Phox2a-, Phox2b-, and tyrosine hydroxylase-immunoreactivity by undifferentiated neural crest-derived cells and different classes of enteric neurons in the embryonic mouse gut. Dev Dyn 216: 137–152.
- 50. Schafer KH, Saffrey MJ, Burnstock G, Mestres-Ventura P (1997) A new method for the isolation of myenteric plexus from the newborn rat gastrointestinal tract. Brain Res Brain Res Protoc 1: 109–113.
- 51. Schafer KH, Hagl CI, Rauch U (2003) Differentiation of neurospheres from the enteric nervous system. Pediatr Surg Int 19: 340–344.
- 52. Lindley RM, Hawcutt DB, Connell MG, Edgar DH, Kenny SE (2009) Properties of secondary and tertiary human enteric nervous system neurospheres. J Pediatr Surg 44: 1249–1255; discussion 1255–1246.
- 53. Swank HA, Eshuis EJ, van Berge Henegouwen MI, Bemelman WA (2011) Short- and long-term results of open versus laparoscopic appendectomy. World J Surg 35: 1221–1226; discussion 1227–1228.
- 54. von Boyen G, Steinkamp M (2011) The role of enteric glia in gut inflammation. Neuron Glia Biol: 1–6.
- 55. Fichter M, Klotz M, Hirschberg DL, Waldura B, Schofer O, et al. (2011) Breast milk contains relevant neurotrophic factors and cytokines for enteric nervous system development. Mol Nutr Food Res 55: 1592–1596.
- 56. Giaroni C, De Ponti F, Cosentino M, Lecchini S, Frigo G (1999) Plasticity in the enteric nervous system. Gastroenterology 117: 1438–1458.
- 57. von Boyen GB, Reinshagen M, Steinkamp M, Adler G, Kirsch J (2002) Enteric nervous plasticity and development: dependence on neurotrophic factors. J Gastroenterol 37: 583–588.
- 58. Schrenk S, Schuster A, Schwab T, Laschke MW, Menger MD, et al. (2012) Endothelial and neural stem cells in the gut: A successful team. Neurogastroenterology and Motility 24: 118–119.
- 59. Eichmann A, Thomas JL (2012) Molecular Parallels between Neural and Vascular Development. Cold Spring Harb Perspect Med.
- 60. Liu MT, Kuan YH, Wang J, Hen R, Gershon MD (2009) 5-HT4 receptor-mediated neuroprotection and neurogenesis in the enteric nervous system of adult mice. J Neurosci 29: 9683–9699.
- 61. Anlauf M, Schafer MK, Eiden L, Weihe E (2003) Chemical coding of the human gastrointestinal nervous system: cholinergic, VIPergic, and catecholaminergic phenotypes. J Comp Neurol 459: 90–111.
- 62. Le Douarin NM, Teillet MA (1973) The migration of neural crest cells to the wall of the digestive tract in avian embryo. J Embryol Exp Morphol 30: 31–48.
- 63. Eng LF (1985) Glial fibrillary acidic protein (GFAP): the major protein of glial intermediate filaments in differentiated astrocytes. J Neuroimmunol 8: 203–214.
- 64. Pekny M, Nilsson M (2005) Astrocyte activation and reactive gliosis. Glia 50: 427–434.
- 65. Silver J, Miller JH (2004) Regeneration beyond the glial scar. Nat Rev Neurosci 5: 146–156.
- 66. Garzon-Muvdi T, Quinones-Hinojosa A (2009) Neural stem cell niches and homing: recruitment and integration into functional tissues. ILAR J 51: 3–23.
- 67. Bath KG, Lee FS (2010) Neurotrophic factor control of adult SVZ neurogenesis. Dev Neurobiol 70: 339–349.
- 68. Landgren H, Curtis MA (2011) Locating and labeling neural stem cells in the brain. J Cell Physiol 226: 1–7.
- 69. Sabuncu MR, Desikan RS, Sepulcre J, Yeo BT, Liu H, et al. (2011) The dynamics of cortical and hippocampal atrophy in Alzheimer disease. Arch Neurol 68: 1040–1048.
- 70. Gibb WR, Lees AJ (1988) The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson’s disease. J Neurol Neurosurg Psychiatry 51: 745–752.
- 71. Hughes AJ, Daniel SE, Blankson S, Lees AJ (1993) A clinicopathologic study of 100 cases of Parkinson’s disease. Arch Neurol 50: 140–148.
- 72. Wakabayashi K, Takahashi H, Takeda S, Ohama E, Ikuta F (1988) Parkinson’s disease: the presence of Lewy bodies in Auerbach’s and Meissner’s plexuses. Acta Neuropathol 76: 217–221.
- 73. Singaram C, Ashraf W, Gaumnitz EA, Torbey C, Sengupta A, et al. (1995) Dopaminergic defect of enteric nervous system in Parkinson’s disease patients with chronic constipation. Lancet 346: 861–864.
- 74. Lebouvier T, Chaumette T, Paillusson S, Duyckaerts C, Bruley des Varannes S, et al. (2009) The second brain and Parkinson’s disease. Eur J Neurosci 30: 735–741.
- 75. Lebouvier T, Neunlist M, Bruley des Varannes S, Coron E, Drouard A, et al. (2010) Colonic biopsies to assess the neuropathology of Parkinson’s disease and its relationship with symptoms. PLoS One 5: e12728.
- 76. Annerino DM, Arshad S, Taylor GM, Adler CH, Beach TG, et al. (2012) Parkinson's disease is not associated with gastrointestinal myenteric ganglion neuron loss. Acta Neuropathol 124: 665–680.
- 77. Xing C, Arai K, Lo EH, Hommel M (2012) Pathophysiologic cascades in ischemic stroke. Int J Stroke 7: 378–385.
- 78. Demir IE, Schafer KH, Tieftrunk E, Friess H, Ceyhan GO (2013) Neural plasticity in the gastrointestinal tract: chronic inflammation, neurotrophic signals, and hypersensitivity. Acta Neuropathol 125: 491–509.
- 79. Neunlist M, Toumi F, Oreschkova T, Denis M, Leborgne J, et al. (2003) Human ENS regulates the intestinal epithelial barrier permeability and a tight junction-associated protein ZO-1 via VIPergic pathways. Am J Physiol Gastrointest Liver Physiol 285: G1028–1036.
- 80. Van Landeghem L, Mahe MM, Teusan R, Leger J, Guisle I, et al. (2009) Regulation of intestinal epithelial cells transcriptome by enteric glial cells: impact on intestinal epithelial barrier functions. BMC Genomics 10: 507.
- 81. Jiang S, Khan MI, Lu Y, Werstiuk ES, Rathbone MP (2005) Acceleration of blood-brain barrier formation after transplantation of enteric glia into spinal cords of rats. Exp Brain Res 162: 56–62.
- 82. Tew EM, Anderson PN, Saffrey MJ, Burnstock G (1994) Transplantation of the postnatal rat myenteric plexus into the adult rat corpus striatum: an electron microscopic study. Exp Neurol 129: 120–129.
- 83. Grundmann D, Loris E, Simon D, Markwart F, Huang W, et al. (2013) Enteric glia: S100b, GFAP and beyond. Glia 61: 53.